The opioid overdose
crisis in North America worsened during the
COVID-19 pandemic, with multiple jurisdictions reporting more deaths
per day due to the fentanyl-contaminated drug supply than COVID-19.
The rapid quantitative detection of fentanyl in the illicit opioid
drug supply or in bodily fluids at biologically relevant concentrations
(i.e., <80 nM) remains a significant challenge. Electroanalytical
techniques are inexpensive and can be used to rapidly detect fentanyl,
but detection limits need to be improved. Herein, we detail the development
of an electrochemical-based fentanyl analytical detection strategy
that used a glassy carbon electrode modified with electrochemically
reduced graphene oxide (ERGO) via electrophoretic deposition. The
resulting surface was further electrochemically reduced in the presence
of fentanyl to enhance the sensitivity. Multiple ERGO thicknesses
were prepared in order to prove the versatility and ability to fine-tune
the layer to the desired response. Fentanyl was detected at <10
ppb (<30 nM) with a limit of detection of 2 ppb and a calibration
curve that covered 4 orders of concentration (from 1 ppb to 10 ppm).
This method was sensitive to fentanyl analogues such as carfentanil.
Interference from the presence of 100-fold excess of other opioids
(heroin, cocaine) or substances typically found in illicit drug samples
(e.g. caffeine and sucrose) was not significant.